Key Messages
-
•Aboriginal peoples living in Canada are among the highest risk populations for diabetes and related complications. Community-based and culturally appropriate prevention strategies and surveillance of diabetes indicators among this high risk population are essential to reducing health disparities.
-
•Efforts to prevent diabetes should focus on diabetes risk factors, including prevention of childhood, adolescent, adult, and pregravid obesity; prevention and optimal management of gestational diabetes; and prevention of modifiable risk factors, such as smoking, inactivity, stress, and unhealthy eating habits.
-
•Screening for diabetes in adults should be considered every 1 to 2 years in Aboriginal individuals with ≥1 additional risk factor(s). Screening every 2 years also should be considered from age 10 years or established puberty in Aboriginal children with ≥1 additional risk factor(s), including exposure to diabetes in utero.
-
•Early identification of diabetes in pregnancy should be emphasized and post-partum screening for diabetes in those with gestational diabetes should be instituted with appropriate follow-up.
-
•Treatment of diabetes in Aboriginal peoples should follow current clinical practice guidelines using community-specific diabetes management programs developed and delivered in partnership with the target communities.
-
•Improvements in systematic care and medical management are needed to help close the substantial care gap between Aboriginal and non-Aboriginal peoples to mitigate diabetes-related morbidity and premature mortality.
Introduction
Around the globe, diabetes incidence and prevalence rates are several times higher among Indigenous peoples compared to the general population (1). In Canada, Aboriginal peoples are a heterogeneous population comprised of individuals of First Nations, Inuit, and Métis heritage living in a range of environments from large cities to small, isolated communities. National survey data have consistently shown that the national age-adjusted prevalence of diabetes is 3 to 5 times higher in First Nations than in the general population (2–5) and population screening has shown rates as high as 26% in individual communities (6). As in most populations where incidence and prevalence rates are higher, age of diagnosis is younger in First Nations peoples (7,8). These rates are similar in other countries where Indigenous populations have been subject to colonization (1). In a recent profile of health status, Métis, aged 19 years and older, in Manitoba, were found to have an age and sex adjusted diabetes rate of 11.8% compared to the provincial rate of 8.8% (9). In 2006, 7% of Métis were reported to have been diagnosed with diabetes while the national prevalence during the same time period was reported at 4% (10). Among the Inuit and Alaska Natives, it has recently been shown that the diabetes prevalence rate has substantially increased and is now comparable with the general Canadian population (11,12).
The higher rate of adverse health outcomes in Aboriginal peoples is associated with a number of factors, including lifestyle (diet and physical activity), genetic susceptibility, and historic-political and psychosocial factors, stemming from a history of colonization that severely undermined Aboriginal values, culture, and spiritual practices (13). Barriers to care that are unique to Aboriginal settings also exacerbate the problem with fragmented healthcare, poor chronic disease management, high healthcare staff turnover, and limited or non-existent surveillance (14). In addition, social determinants of health, including low income, lack of education, high unemployment, poor living conditions, lack of social support, negative stereotyping and stigmatization, and poor access to health services compound the problem (14). Different understandings of the etiology of health and illness from the holistic, collective social experience adopted by many Indigenous peoples to the traditional biomedical model which centers the disease within the individual may also influence care (15).
Among First Nations peoples, a gender difference exists with more females impacted by type 2 diabetes than males (7,16). This is most striking during reproductive years, resulting in recent age standardized prevalence rates of over 20% among First Nations women compared to about 16% among First Nations men. In addition, diabetes prevalence rates have more than tripled from 1980 to 2005 among First Nations children (8,17). Similarly, incidence rates of type 2 diabetes among Indigenous youth in Australia have been documented to be 6.1 times that of non-Indigenous youth (18). Métis men and women are reported to have a similar prevalence of diabetes (10).
Aboriginal women in Canada also experience gestational diabetes mellitus (GDM) rates 2 to 3 times higher than others (19,20), in part related to an interaction of Aboriginal ethnicity with pregravid adiposity (19,21). High GDM rates preceded the appearance of the type 2 diabetes epidemic in remote communities surveyed in the early 1990s (22) and increasing GDM rates (20) have paralleled increases in high birth weight rates over several decades. Both maternal GDM (23) and high birth weight (24) are predictors for type 2 diabetes in the offspring (25) and likely contribute to the higher type 2 diabetes rates in First Nations women compared to men (7).
While genetic factors are important in the epidemic of type 2 diabetes among Indigenous peoples (26), its rapid appearance over a few decades in genetically diverse populations is likely the result of an interaction of local genetic mutations with numerous social stressors and lifestyle factors (27–32). Recent research suggests that epigenetic factors play a key role in the interaction between genes and the environment, influencing the development of diabetes complications (33,34). Inequities in the social determinants of health brought about through colonization (14) contribute to the main risk factors for type 2 diabetes in Aboriginal peoples, such as decreased rates of physical activity, stress, dietary acculturation and an unhealthy diet, food insecurity, obesity/metabolic syndrome, and high rates of diabetes during pregnancy.
Complications and Mortality Due to Diabetes
Indigenous peoples with diabetes also experience disparities in diabetes-related complications and mortality. Higher prevalence rates of microvascular disease, including chronic kidney disease (CKD) (35), lower limb amputation (9,36), foot abnormalities (37,38), and more severe retinopathy (39), are found in Aboriginal peoples with diabetes than in the general population with diabetes. Aboriginal peoples also are burdened by higher rates of macrovascular disease (9,15) and exhibit higher rates of cardiometabolic risk factors, including smoking, obesity, and hypertension (9,35,40), that may indicate a future increase in cardiovascular morbidity and mortality.
As in other Indigenous populations, First Nations people with diabetes have high rates of albuminuria (41) and are more likely than others to progress to end-stage renal disease (ESRD) (42). Potentially modifiable risk factors for kidney disease progression include poor glycemic control, systolic hypertension, smoking, and insufficient use of angiotensin-converting-enzyme (ACE) inhibitors (41,43) as well as periodontal disease (44). Likely relevant for other chronic diabetic complications, longer duration of diabetes (41,45) related to younger adult onset (45) is associated with higher ESRD rates and differential mortality and highlights the urgent need for primary diabetes prevention. The provincial dialysis initiation rate is higher for Métis than other Manitobans (0.46% vs. 0.34%) (9). On a positive note, ESRD incidence among Aboriginal peoples has stabilized since the early 1990s in both the United States (46) and Canada (42), and is probably due to the introduction of ACE inhibitors and application of interdisciplinary chronic disease care models (46).
The prevalence of metabolic syndrome is elevated among both First Nations adults (47) and children (48,49) and, like type 2 diabetes, disproportionately affects females with rates as high as 45% in Oji-Cree women. Increased adiposity and dysglycemia are more common components than hypertension (47), and non-traditional risk factors, such as elevated C-reactive protein are also elevated (48). There is a strong relationship between metabolic syndrome and later type 2 diabetes (50,51). Thus, Aboriginal peoples with metabolic syndrome should be targeted by programs designed to prevent type 2 diabetes since interventions, such as increased physical activity (52) and consumption of long chain omega 3 fatty acids (53), have been shown to improve glucose tolerance in Aboriginal peoples.
A reversal in long-term trends for decreasing mortality among American Indians since the mid-1980s appears primarily due to the direct and indirect effects of type 2 diabetes (54). Surveillance data from Alberta indicate that Aboriginal peoples with diabetes have mortality rates 2 to 3 times higher than the general population with diabetes (8). Provincially, Métis with diabetes are significantly more likely to die within a 5-year period than other Manitobans with diabetes (20.8% vs. 18.6%) (9). In British Columbia, First Nations peoples with diabetes have nearly twice the mortality rate than First Nations peoples without diabetes (55). Additionally, administrative data have demonstrated increased hospitalizations for heart disease among First Nations people in Ontario, despite decreases in the general population (56). Healthcare costs for Aboriginal peoples with diabetes have been shown to be considerably higher than costs in the general population with diabetes due to higher use of physician and hospital services (57). Increased morbidity and mortality among First Nations people are at least partly due to poorer quality of diabetes care (35,58,59).
Screening
Routine medical care for Aboriginal peoples of all ages should include identification of modifiable risk factors, such as obesity, abnormal waist circumference (WC) or body mass index (BMI), physical inactivity, smoking, and unhealthy eating habits. Screening for diabetes with a fasting plasma glucose (FPG) test, an A1C, or an oral glucose tolerance test (OGTT) should be considered every 1 to 2 years in individuals with ≥1 additional risk factor(s). Screening every 2 years also should be considered from age 10 or established puberty (60) in Aboriginal children with ≥1 additional risk factor(s), including exposure to diabetes in utero (see Screening for Type 1 and Type 2 Diabetes chapter, p. S12). Regular screening and follow-up should be done in children who are very obese (BMI ≥99.5 percentile) (see Type 1 Diabetes in Children and Adolescents, p. S153; Type 2 Diabetes in Children and Adolescents, p. S163). While an OGTT remains the standard for the diagnosis of diabetes, the A1C has a distinct appeal for testing in this population as it is relatively inexpensive and does not require fasting.
Systematic screening for diabetes and related complications has taken place in several Aboriginal community settings across North America. Screening has proved possible in both rural and remote communities through appropriate dialogue, respect and planning, the provision of concomitant health education and care, and the promotion of follow-up (58,61–64). In the United States, a kidney evaluation program screened 89,552 participants in 49 states, 4.5% of whom were Native Americans (63). In Alberta, substantial numbers of Aboriginal individuals with abnormalities have been identified through community-based screening (64), particularly First Nations people with documented risk factors.
Regular screening, follow-up, and surveillance in individuals with prediabetes (IFG and/or IGT), history of GDM, or polycystic ovary syndrome (PCOS) should be encouraged, as 20 to 50% of high risk individuals with IFG may have a 2-hour plasma glucose ≥11.1 mmol/L (65). Lifestyle or metformin should be initiated as treatment of prediabetes and ongoing monitoring should be instituted.
Primary Prevention
Efforts to prevent diabetes should focus on all diabetes risk factors, including prevention of childhood, adolescent, adult, and pregravid obesity; and prevention and optimal management of diabetes in pregnancies to reduce macrosomia and diabetes risk in offspring. Prevention strategies in communities should be implemented in collaboration with community leaders, healthcare professionals, and funding agencies to engage entire communities, promote environmental changes, and prevent increased risk of diabetes (66,67). Such partnerships are important in incorporating traditions and local culture, building both trusting relationships and community capacity, and increasing diabetes-related knowledge (68). Programs should be developed in collaboration with communities and implemented within the framework of available health resources and infrastructure of each community and promote traditional activities and foods (provided they are safe, acceptable, and accessible).
Prevention of childhood obesity through moderate interventions, starting in infancy, has shown promise (69). In Zuni First Nations children in the United States, an educational component targeting decreased consumption of sugared beverages, knowledge of diabetes risk factors, and a youth-oriented fitness centre significantly decreased insulin resistance (70). These types of interventions aimed at decreasing childhood obesity, as well as efforts to promote breast-feeding in the first year of life (23), may help to reduce the risk for diabetes. As well, strategies aimed at the prevention of pregravid obesity prior to first conception or subsequent pregnancy may be important tools to decrease the incidence of GDM and type 2 diabetes in pregnancy, thereby potentially decreasing the incidence of diabetes in subsequent generations of Aboriginal peoples (71–73).
Management
Lifestyle intervention programs targeted towards Aboriginal people with diabetes show modest results. Targeted programs to improve diet and increase exercise have been effective in improving glycemic control (74,75), reducing caloric intake (76), reducing weight (74), reducing WC and diastolic blood pressure (77), and increasing folate intake (78). A key component to all successful programs is cultural appropriateness.
Similar to prevention strategies, treatment of diabetes in Aboriginal peoples should be in the context of local traditions, language, and culture, while also adhering to current clinical practice guidelines. While most diabetes education programs work most effectively when delivered by multidisciplinary teams, in Aboriginal communities, where access to physicians is often limited, strategies to improve care should focus on building capacity of existing front-line staff (community health care providers, nurses) to implement clinical practice guidelines (58,79,80).
Working with community healthcare providers and community leaders assures that local resources and challenges, such as access to healthy foods, geographic location, and isolation level, are acknowledged and considered and that programs developed are community-directed (81–84). A diabetes management program incorporating self-management and patient education addressing diet and exercise within a Hawaiian/Samoan Indigenous population utilized community health workers in the application of clinical practice guidelines and a chronic disease management model. The study demonstrated a significant improvement in A1C levels and important changes in patient knowledge of reducing consumption of non-healthy foods (82). Maori and Pacific Islander adults with type 2 diabetes and CKD received community care provided by local healthcare assistants to manage hypertension and demonstrated a reduction in systolic blood pressure and in 24-hour urine protein, and a greater number of prescribed antihypertensives. Left ventricular mass and left atrial volume progressed in the usual care group, but not in the intervention group (85).
Systems Intervention
Comprehensive management of diabetes in small remote communities (where many Aboriginal people live) remains difficult due to discontinuities in staffing, lack of work-practice support, and services not adapted to individual's needs (86). Existing intervention studies have assessed impact on clinical outcomes, process measures of care, lifestyle changes, and patient satisfaction. The main types of interventions that have been tested include: expanding the scope of practice for nurses and allied care (82,87–89), increasing access to care and screening (90,91), multifaceted interventions designed to improve quality of care, and targeting patients through lifestyle programs (92).
Expanding the scope of practice for nurses and allied health professionals in diabetes care is an effective strategy, and particularly important where doctors are scarce. The DREAM 3 study used home and community care workers to implement a nurse-led algorithm-driven hypertension management program which produced sustained reductions in blood pressure in a Saskatchewan First Nations community through a randomized controlled trial (87–89). Algorithm-based screening and management of renal and cardiovascular abnormalities by local health workers supported by nurses and physicians reduced renal failure (93,94). Algorithm-based, nurse-led management showed improvement in hypertension and cholesterol (95–97). Nurse case management has shown benefit in urban and rural settings, increasing screening rates and compliance (98,99). Multidisciplinary teams, occasionally including Aboriginal health workers, also have shown benefit (100–102). The SANDS study demonstrated that aggressive lipid targets could be safely maintained in Indigenous peoples with diabetes with the help of standardized algorithms, point-of-care lipid testing, and non-physician providers (103).
For mitigation of geographic access to diabetes care, mobile screening and treatment units that target Aboriginal communities have been found to be effective in Western Canada. Mobile units equipped with staff, lab, and diagnostic equipment showed significant improvements in BMI, blood pressure, A1C, and lipid levels (90,91). An outreach team conducting small group academic detailing with clinicians improved blood pressure and client satisfaction (104). Retinal photography has been shown to be an effective strategy to increase access to screening for diabetic retinopathy in remote communities (105).
Given the multiple barriers to high quality care, multifaceted interventions also have shown benefit. These include: diabetes registries, recall systems, care plans, training for community health workers, and an outreach service. These have been found to be effective in Australia, but it is not clear which elements are key (86,106–108).
There is an urgent need for systematic and validated surveillance of prevalence, incidence, and morbidity and mortality rates due to type 2 diabetes in First Nations communities (35). Surveillance systems in Australia monitoring diabetes rates in their Aboriginal peoples have shown improvements in quality of care (109). In the United States, federally funded on-reserve programs include diabetes registries, use of flow charts, annual chart audits with continuous quality assurance, full-time dedicated diabetes clinical staff, and funding for community initiatives. These programs have been associated with consistent improvements in diabetes quality measures (110). The James Bay Cree in Quebec have instituted a regional diabetes surveillance system that tracks clinical outcomes, including complications (111,112). A registry program also has been developed for Queensland in Australia (113). Surveillance systems incorporating diabetes registries would allow organizations and providers to document clinical care, monitor trends in care, identify community needs, evaluate programs, and facilitate policy development (8,55,109,114). A national surveillance program should be considered in Canada for on- and off-reserve Aboriginal communities.
Recommendations
-
1.Starting in early childhood, Aboriginal people should be evaluated for modifiable risk factors of diabetes (e.g. obesity, lack of physical activity, unhealthy eating habits), prediabetes, or metabolic syndrome [Grade D, Consensus, see Type 2 Diabetes in Children and Adolescents, p. S163].
-
2.Screening for diabetes in Aboriginal children and adults should follow guidelines for high risk populations (i.e. earlier and at more frequent intervals depending on presence of additional risk factors) [Grade D, Consensus, see Screening for Type 1 and Type 2 Diabetes, p. S12; Type 2 Diabetes in Children and Adolescents, p. S163].
-
3.Culturally appropriate primary prevention programs for children and adults should be initiated in and by Aboriginal communities with support from the relevant health system(s) and agencies to assess and mitigate the environmental risk factors, such as:
-
•geographic and cultural barriers
-
•food insecurity
-
•psychological stress
-
•insufficient infrastructure
-
•settings that are not conducive to physical activity
-
[Grade D, Consensus].
-
4.Management of prediabetes and diabetes in Aboriginal peoples should follow the same clinical practice guidelines as those for the general population with respect for, and sensitivity to, particular language, cultural history, traditional beliefs and medicines, and geographic issues as they relate to diabetes care and education in Aboriginal communities across Canada. Programs should adopt a holistic approach to health that addresses a broad range of stressors shared by Aboriginal peoples [Grade D, Consensus].
-
5.Aboriginal peoples in Canada should have access in their communities to a diabetes management program that would include an interprofessional nurse-led team, diabetes registries, and ongoing quality assurance and surveillance programs [Grade D, Level 4 (35,80,87)].
-
6.Aboriginal women should attempt to reach a healthy body weight prior to conception to reduce their risk for gestational diabetes [Grade D, Level 4 (6,19)].
-
7.Programs to detect pre-gestational and gestational diabetes, provide optimal management of diabetes in pregnancy, and timely post-partum follow-up should be instituted for all Aboriginal women to improve perinatal outcomes, manage persistent maternal dysglycemia, and reduce type 2 diabetes rates in their children [Grade D, Level 4 (115,116), see Diabetes and Pregnancy, p. S168].
Related Websites
First Nation, Inuit and Aboriginal Health. Available at: http://www.hc-sc.gc.ca/fniah-spnia/diseases-maladies/diabete/index-eng.php. Accessed March 21, 2013.
National Aboriginal Diabetes Association. Available at: http://www.nada.ca. Accessed March 21, 2013.
References
-
1 C.H. Yu B. Zinman Type 2 diabetes and impaired glucose tolerance in Aboriginal populations: A global perspective Diabetes Res Clin Pract 78 2007 159 170
-
2 C. Green J. Blanchard T.K. Young The epidemiology of diabetes in the Manitoba-registered First Nation population: Current patterns and comparative trends Diabetes Care 26 2003 1993 1998
-
3 First Nations Centre, National Aboriginal Health Organization First Nations regional longitudinal health survey (RHS) 2002/03-results for adults, youth and children living in First Nations communities 2005 First Nations Centre, National Aboriginal Health Organization Ottawa
-
4 First Nations Information Governance Centre First Nations regional longitudinal health survey (RHS). RHS phase 2 (2008/2010) preliminary results. Adult, youth, child 2011 First Nations Information Governance Centre Ottawa
-
5 T.K. Young J. Reading B. Elias Type 2 diabetes mellitus in Canada's First Nations: Status of an epidemic in progress CMAJ 163 2000 561 566
-
6 S.B. Harris J. Gittelsohn A. Hanley The prevalence of NIDDM and associated risk factors in Native Canadians Diabetes Care 20 1997 185 187
-
7 R.F. Dyck N. Osgood T.H. Lin Epidemiology of diabetes mellitus among First Nations and non-First Nations adults CMAJ 182 3 2010 249 256
-
8 R.T. Oster J.A. Johnson B.R. Hemmelgarn Recent epidemiologic trends of diabetes mellitus among status Aboriginal adults CMAJ 183 2011 E803 E808
-
9 P.J. Martens J. Bartlett E. Burland Profile of Metis Health Status and Healthcare Utilization in Manitoba: A population-based study June 2010 Manitoba Centre for Health Policy Winnipeg, MB
-
10 Janz T, Seto J, Turner A. Aboriginal peoples survey, 2006, no. 4. An overview of the health of the Métis population. Statistics Canada. 2009. http:// www.statcan.gc.ca/pub/89-637-x/2009006/art/art1-eng.htm . Accessed July 7, 2012.
-
11 G.M. Egeland Z. Cao T.K. Young Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: The international polar year inuit health survey for adults 2007-2008 CMAJ 183 2011 E553 E558
-
12 M.L. Narayanan C.D. Schraer L.R. Bulkow Diabetes prevalence, incidence, complications and mortality among Alaska Native people 1985-2006 Int J Circumpolar Health 69 3 2010 236 252
-
13 C. Nettleton Symposium on the social determinants of Indigenous health An overview of current knowledge of the social determinants of Indigenous health 2007 World Health Organization Geneva, Switzerland
-
14 M. Gracey M. King Indigenous health part 1: Determinants and disease patterns Lancet 374 2009 65 75
-
15 M. Naqshbandi S.B. Harris J.G. Esler Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review Diabetes Res ClinPract 82 1 2008 1 17
-
16 A. Fagot-Campagna D.J. Pettit M.M. Engelgau Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective J Pediatr 136 5 2000 664 672
-
17 R.F. Dyck N.D. Osgood A. Gao The epidemiology of diabetes mellitus among First Nations and non-First Nations children in Saskatchewan Canadian Journal of Diabetes 36 2012 19 24
-
18 M.E. Craig G. Femia V. Broyda Type 2 diabetes in Indigenous and non-Indigenous children and adolescents in New South Wales Med J Aust 186 10 2007 497 499
-
19 R. Dyck H. Klomp L.K. Tan A comparison of rates, risk factors, and outcomes of gestational diabetes between Aboriginal and non-Aboriginal women in the Saskatoon health district Diabetes Care 25 2002 487 493
-
20 N. Aljohani B.M. Rempel S. Ludwig Gestational diabetes in Manitoba during a twenty-year period Clin Invest Med 31 2008 E131 E137
-
21 S.B. Harris L.E. Caulfield M.E. Sugamori The epidemiology of diabetes in pregnant Native Canadians Diabetes Care 20 9 1997 1422 1425
-
22 R.F. Dyck L. Tan V.H. Hoeppner Body mass index, gestational diabetes and diabetes mellitus in three northern Saskatchewan Aboriginal communities Chronic Diseases Canada 16 1 1995 24 26
-
23 T.K. Young P.J. Martens S.P. Taback Type 2 diabetes mellitus in children: Prenatal and early infancy risk factors among native Canadians Arch Pediatr Adolesc Med 156 2002 651 655
-
24 R.F. Dyck H. Klomp L. Tan From “thrifty genotype” to “hefty fetal phenotype”: The relationship between high birth weight and diabetes in Saskatchewan registered Indians Can J Public Health 92 5 2001 340 344
-
25 R.F. Dyck P.J. Cascagnette H. Klomp The importance of older maternal age and other birth-related factors for diabetes in the offspring: Particular implications for First Nations women? Can J Diabetes 34 1 2010 41 49
-
26 R.L. Hanson C. Bogardus D. Duggan A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array Diabetes 56 12 2007 3045 3052
-
27 L. Bian R.L. Hanson V. Ossowski Variants in ASK1 are associated with skeletal muscle ASK1 expression, in vivo insulin resistance, and type 2 diabetes in Pima Indians Diabetes 59 5 2010 1276 1282
-
28 L. Bian R.L. Hanson Y.L. Muller Variants in ACAD10 are associated with type 2 diabetes, insulin resistance and lipid oxidation in Pima Indians Diabetologia 53 7 2010 1349 1353
-
29 G.H. Degaffe D.L. Vander Jagt A. Bobelu Distribution of glyoxalase I polymorphism among Zuni Indians: The Zuni Kidney Project Journal of Diabetes and its Complications 22 4 2008 267 272
-
30 R.A. Hegele H. Cao S.B. Harris The hepatocyte nuclear factor-1alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes Diabetes Care 22 1999 524
-
31 V.S. Voruganti S.A. Cole S.O. Ebbesson Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos American Journal of Clinical Nutrition 91 6 2010 1574 1583
-
32 Y. Iwasaki J. Bartlett J. O'Neil An examination of stress among Aboriginal women and men with diabetes in Manitoba, Canada Ethn Health 9 2 2004 189 212
-
33 L. Pirola A. Balcerczyk J. Okabe Epigenetic phenomena linked to diabetic complications Nature Reviews Endocrinology 6 12 2010 665 675
-
34 M.A. Reddy R. Natarajan Epigenetic mechanisms in diabetic vascular complications Cardiovascular Research 90 3 2010 421 429
-
35 S.B. Harris M. Naqshbandi O. Bhattacharyya Major gaps in diabetes clinical care among Canada's First Nations: Results of the CIRCLE study Diabetes Res Clin Pract 92 2 2011 272 279
-
36 P.J. Martens B.D. Martin J.D. O'Neil Diabetes and adverse outcomes in a First Nations population: Associations with healthcare access, and socioeconomic and geographical factors Can J Diabetes 31 3 2007 223 232
-
37 J. Chuback J.M. Embil E. Sellers Foot abnormalities in Canadian Aboriginal adolescents with type 2 diabetes Diabet Med 24 2007 747 752
-
38 G. Rose F. Duerksen E. Trepman Multidisciplinary treatment of diabetic foot ulcers in Canadian Aboriginal and non-Aboriginal people Foot and Ankle Surgery 14 2008 74 81
-
39 S.A. Ross A. McKenna S. Mozejko Diabetic retinopathy in Native and nonnative Canadians Experimental Diabetes Research 2007 2007 76271
-
40 R.T. Oster E.L. Toth Differences in the prevalence of diabetes risk-factors among First Nation, Métis and non-Aboriginal adults attending screening clinics in rural Alberta, Canada Rural Remote Health 9 2 2009 1170
-
41 R.F. Dyck N. Sidhu H. Klomp Differences in glycemic control and survival predict higher ESRD rates in diabetic First Nations adults Clin Invest Med 33 6 2010 E390 E397
-
42 R.F. Dyck N.D. Osgood T.H. Lin End Stage Renal Disease among people with diabetes: A comparison of First Nations people and other Saskatchewan residents from 1981-2005 Can J Diabetes 34 4 2010 324 333
-
43 J. Xu E.T. Lee R.B. Devereux A longitudinal study of risk factors for incident albuminuria in diabetic American Indians Am J Kidney Dis 51 3 2008 415 424
-
44 W.A. Shultis E.J. Weil H.C. Looker Effect of periodontitis on overt nephropathy and ESRD in type 2 diabetes Diabetes Care 30 2 2007 306 311
-
45 M.E. Pavkov P.H. Bennett W.C. Knowler Effect of youth-onset type 2 diabetes mellitus on end-stage renal disease and mortality in young and middle-aged Pima Indians JAMA 296 4 2010 421 426
-
46 A.S. Narva T.D. Sequist Reducing health disparities in American Indians with chronic kidney disease Seminars Neph 30 1 2010 19 25
-
47 J. Liu A.J.G. Hanley T.K. Young Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada International Journal of Obesity 30 2006 669 676
-
48 R. Retnakaran B. Zinman P.W. Connelly Nontraditional cardiovascular risk factors in pediatric metabolic syndrome J Pediatr 148 2006 176 182
-
49 S. Kaler K. Ralph-Campbell S. Pohar High rates of the metabolic syndrome in a First Nations community in Alberta: Prevalence and determinants in adults and children Int J Circumpolar Health 65 5 2006 389 402
-
50 S.H. Ley S.B. Harris M. Mamakeesick Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community CMAJ 180 6 2009 617 624
-
51 H. Wang N.M. Shara J.G. Umans Incidence rates and predictors of diabetes in those with pre-diabetes: The Strong Heart Study Diabetes Metab Res Rev 26 2010 378 385
-
52 M.S. Mitchell C.A. Gaul P.J. Naylor Habitual moderate-to-vigorous physical activity is inversely associated with insulin resistance in Canadian First Nations youth Pediatric Exercise Science 22 2010 254 265
-
53 S.O.E. Ebbesson M.E. Tejero E.D. Nobmann Fatty acid consumption and metabolic syndrome components: The GOCADAN study JCMS 2 4 2007 244 249
-
54 S.J. Kunitz Ethics in public health research: Changing patterns of mortality among American Indians Am J of Public Health 98 3 2008 404 411
-
55 Public Health Agency of Canada. Report from the National Diabetes Surveillance System: Diabetes in Canada, 2009. Available at http://www.phac-aspc.gc.ca/publicat/2009/ndssdic-snsddac-09/1-eng.php . Accessed June 10, 2011.
-
56 B.R. Shah J.E. Hux B. Zinman Increasing rates of ischemic heart disease in the Native population of Ontario, Canada Arch Intern Med 160 2000 1862 1866
-
57 S.L. Pohar J.A. Johnson Health care utilization and costs in Saskatchewan's registered Indian population with diabetes BMC Health Services Research 7 2007 126
-
58 R.T. Oster S. Virani D. Strong Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta Can Fam Physician 55 2009 386 393
-
59 H. Klomp R.F. Dyck N. Sidhu Measuring quality of diabetes care by linking health care system databases with laboratory data BMC Research Notes 3 2010 233 10.1186/1756-0500-3-233
-
60 S. Gahagan J. Silverstein American Academy of Pediatrics Committee on Native American Child Health. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children Pediatrics 112 2003 328 347
-
61 A.J. Jin D. Martin D. Maberley Evaluation of a mobile diabetes care telemedicine clinic serving Aboriginal communities in Northern British Columbia, Canada Int J Circumpolar Health 63 suppl 2 2004 124 128
-
62 C. Panagiotopoulos J. Rozmus R.E. Gagnon Diabetes screening of children in a remote First Nations community on the west coast of Canada: Challenges and solutions Rural Remote Health 7 3 2007 771
-
63 J.A. Vassalotti S. Li P.A. McCullough Kidney early evaluation program: A Community-Based Screening Approach to Address Disparities in Chronic Kidney Disease Semin Nephrol 30 1 2010 66 73
-
64 R.T. Oster K. Ralph-Campbell T. Connor What happens after community-based screening for diabetes in rural and Indigenous individuals? Diabetes Res ClinPract 88 3 2010 e28 e31
-
65 R.C. Perry R.R. Shankar N. Fineberg HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose Diabetes Care 24 2001 465 471
-
66 L.S. Ho J. Gittelsohn R. Rimal An integrated multi-institutional diabetes prevention program improves knowledge and healthy food acquisition in northwestern Ontario First Nations Health Educ Behav 35 4 2008 561 573
-
67 K.J. Coppell D.C. Tipene-Leach H.L. Pahau Two-year results from a community-wide diabetes prevention intervention in a high risk indigenous community: The Ngati and healthy project Diabetes Res Clin Pract 85 2 2009 220 227
-
68 S.T. Roussos S.B. Fawcett A review of collaborative partnerships as a strategy for improving community health Annu Rev Public Health 21 2000 369 402
-
69 M. Hakanen H. Langstrom T. Kaitosaari Development of overweight in an atherosclerosis prevention trial started in early childhood. The STRIP study Int J Obes (Lond) 30 2006 618 626
-
70 C. Ritenbaugh N.I. Teufel-Shone M.G. Aickin A lifestyle intervention improves plasma insulin levels among Native American high school youth Prev Med 36 2003 309 319
-
71 E.A. Brennand D. Dannenbaum N.D. Willows Pregnancy outcomes of First Nation women in relation to pregravid weight and pregnancy weight gain J Obstet Gynaecol Can 27 2005 936 944
-
72 H. Dean B. Flett Natural history of type 2 diabetes diagnosed in childhood: Long-term follow-up in young adult years [abstract] Diabetes 51 suppl 2 2002 A24 Abstract 99-OR
-
73 R.F. Dyck M.S. Sheppard H. Cassidy Preventing NIDDM among Aboriginal people: Is exercise the answer? Description of a pilot project using exercise to prevent gestational diabetes Int J Circumpolar Health 57 suppl 1 1998 375 378
-
74 S.S. Gilliland S.P. Azen G.E. Perez Strong in body and spirit: Lifestyle intervention for Native American adults with diabetes in New Mexico Diabetes Care 25 1 2002 78 83
-
75 C. Robertson K. Kattelmann C. Ren Control of type 2 diabetes mellitus using interactive internet-based support on a Northern Plains Indian reservation: A pilot study Topics in Clinical Nutrition 22 2 2007 185 193
-
76 E.J. Mayer-Davis K.C. Sparks K. Hirst Diabetes Prevention Program Research Group. Dietary intake in the Diabetes Prevention Program cohort: Baseline and 1-year post-randomization Annals of Epidemiology 14 10 2004 763 772
-
77 L.C.K. Chan R. Ware J. Kesting Short term efficacy of a lifestyle intervention programme on cardiovascular health outcome in overweight Indigenous Australians with and without type 2 diabetes mellitus. The healthy lifestyle programme (HELP) Diabetes Research and Clinical Practice 75 1 2007 65 71
-
78 K. Gray-Donald E. Robinson A. Collier Intervening to reduce weight gain in pregnancy and gestational diabetes mellitus in Cree communities: An evaluation CMAJ 163 10 2000 1247 1251
-
79 J. Curtis S. Lipke S. Effland Effectiveness and safety of medication adjustment by nurse case managers to control hyperglycemia The Diabetes Educator 35 5 2009 851 856
-
80 G. Pylypchuk L. Vincent J. Wentworth Diabetes Risk Evaluation and Microalbuminuria (DREAM) Studies: Ten Years of Participatory Research With A First Nation's Home and Community Model for Type 2 Diabetes Care in Northern Saskatchewan Int J Circumpolar Health 67 2-3 2008 191 202
-
81 J.G. Bartlett Y. Iwasaki B. Gottlieb Framework for Aboriginal-guided decolonizing research involving Métis and First Nations persons with diabetes Social Science & Medicine 65 2007 2371 2382
-
82 S. Beckham S. Bradley A. Washburn Diabetes Management: Utilizing community health care workers in a Hawaiian/Samoan population J of Health Care for the Poor and Underserved 19 2008 416 442
-
83 M. Cargo T. Delormier L. Lévesque Can the democratic ideal of participatory research be achieved? An inside look at an academic-indigenous community partnership Health Education Research 23 5 2008 904 914
-
84 S.D. Newman J.O. Andrews G.S. Magwood Community advisory boards in community-based participatory research: A synthesis of best processes Prev Chronic Dis 8 3 2011 1 12
-
85 C. Hotu W. Bagg J. Collins A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: A randomized controlled trial Nephrol Dial Transplant 25 10 2010 3260 3266
-
86 R.S. Bailie D. Si G.W. Robinson A multifaceted health service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care Med J Aust 181 2004 195 200
-
87 S.W. Tobe G. Pylypchuk J. Wentworth Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: The Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial CMAJ 174 9 2006 1267 1271
-
88 S.W. Tobe M.M. Lum-Kwong N. Perkins Heart and stroke foundation of Ontario (HSFO) high blood pressure strategy's hypertension management initiative study protocol BMC Health Services Research 8 1 2008 251
-
89 S. Tobe L. Vincent J. Wentworth Blood pressure 2 years after a chronic disease management intervention study Int J Circumpolar Health 69 1 2010 50 60
-
90 R.T. Oster S. Shade D. Strong Improvements in indicators of diabetes-related health status among First Nations individuals enrolled in a community-driven diabetes complications mobile screening program in Alberta, Canada Can J Public Health 101 5 2010 410 414
-
91 S. Virani D. Strong M. Tennant Rationale and implementation of the SLICK project: Screening for Limb, I-eye, Cardiovascular and Kidney (SLICK) complications in individuals with type 2 diabetes in Alberta's first nations communities Canadian Journal of Public Health 97 3 2006 241 247
-
92 K. Ralph-Campbell S.L. Pohar L.M. Guirguis Aboriginal Participation in the DOVE study Can J Public Health 97 4 2006 305 309
-
93 W.E. Hoy P.R. Baker A.M. Kelly Reducing premature death and renal failure in Australian Aboriginals: A community-based cardiovascular and renal protective program Medical Journal of Australia 172 10 2000 473 478
-
94 W.E. Hoy S.N. Kondalsamy-Chennakesavan J.L. Nicol Clinical outcomes associated with changes in a chronic disease treatment program in an Australian aboriginal community Medical Journal of Australia 183 6 2005 305 309
-
95 M. Russell J.L. Fleg W.J. Galloway Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes–the Stop Atherosclerosis in Native Diabetics Study (SANDS) Am Heart J 152 5 2006 867 875
-
96 M.R. Weir F. Yeh A. Silverman Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: The SANDS trial Journal of Clinical Hypertension 11 10 2009 540 548
-
97 C. Wilson C.C. Huang N. Shara Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) J Clin Lipidol 4 3 2010 165 172
-
98 C. Wilson J. Curtis S. Lipke Nurse case manager effectiveness and case load in a large clinical practice: Implications for workforce development Diabet Med 22 2005 1116 1120
-
99 T.W. Kenealy K.S. Eggleton E.M. Robinson Systematic care to reduce ethnic disparities in diabetes care Diabetes Research and Clinical Practice 89 3 2010 256 261
-
100 S. Rith-Najarian C. Branchaud O. Beaulieu Reducing lower-extremity amputations due to diabetes: application of the Staged Diabetes Management approach in a primary care setting Journal of Family Practice 47 2 1998 127 132
-
101 D. Simmons Impact of an integrated approach to diabetes care at the Rumbalara Aboriginal Health Service Internal Medicine Journal 33 12 2003 581 585
-
102 J. Cooper S. Moore L. Palmer Partnership approach to indigenous primary health care and diabetes: A case study from regional New South Wales Australian Journal of Rural Health 15 1 2007 67 70
-
103 M. Russell A. Silverman J.L. Fleg Achieving lipid targets in adults with type 2 diabetes: The Stop Atherosclerosis in Native Diabetics Study Journal of Clinical Lipidology 4 5 2010 435 443
-
104 S.R. Majumdar L.M. Guirguis E.L. Toth Controlled Trial of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes Diabetes Care 26 11 2003 3061 3066
-
105 D. Maberley H. Walker A. Koushik Screening for diabetic retinopathy in James Bay, Ontario: A cost-effectiveness analysis CMAJ 168 2003 160 164
-
106 R.A. McDermott B.A. Schmidt A. Sinha Improving diabetes care in the primary healthcare setting: A randomised cluster trial in remote indigenous communities Medical Journal of Australia 174 10 2001 497 502
-
107 R. McDermott F. Tulip B. Schmidt Sustaining better diabetes care in remote indigenous Australian communities British Medical Journal 327 7412 2003 428 430
-
108 R. Bailie D. Si M. Dowden Improving organisational systems for diabetes care in Australian Indigenous communities BMC Health Services Research 7 2007 67
-
109 D. Si R. Baille M. Dowden Assessing quality of diabetes care and its variation in Aboriginal community health centres in Australia Diabetes Metab Res Rev 26 2010 464 473
-
110 Indian Health Service National Diabetes Program. Special Diabetes Program for Indians. 2011 Report to Congress. “Making Progress Toward a Healthier Future”. 2011.
-
111 D. Dannenbaum M. Verronneau J. Torrie Comprehensive computerized diabetes registry. Serving the Cree of EeyouIstchee (easter James Bay) Can Fam Physician 45 1999 364 370
-
112 D. Dannenbaum E. Kuzmina P. Lejeune Prevalence of Diabetes and Diabetes-related Complications in First Nations Communities in Northern Quebec (EeyouIstchee), Canada Can J Diabetes 32 1 2008 46 52
-
113 R.A. McDermott B.G. McCulloch S.K. Campbell Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999–2005 Med J Aust 186 2007 505 508
-
114 R. Birtwhistle K. Keshavjee A. Lambert-Lanning Building a Pan-Canadian Primary Care Sentinel Surveillance Network: Initial Development and Moving Forward JABFM 22 4 2009 412 422
-
115 D. Dabelea W. Knowler D. Pettitt Effect of diabetes in pregnancy on offspring: Follow-up research in the Pima Indians The Journal of Maternal-Fetal Medicine 9 2000 83 88
-
116 N. Osgood R. Dyck W. Grassmann The inter-and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes American Journal of Public Health 101 2011 173 179
© 2013 Canadian Diabetes Association. To cite this article, please refer to For citation.